During the past decade, Hôpital Sainte Marguerite conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Sainte Marguerite" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 6 trials, followed by "Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète" with 5 trials sponsored, "ANRS, Emerging Infectious Diseases" with 4 trials sponsored, "Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba" with 3 trials sponsored and "Assistance Publique Hopitaux De Marseille" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Sainte Marguerite" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Caisse Nationale de Solidarité pour l'Autonomie" with 1 trials as a collaborator and "Direction Générale de la Santé, France" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Sainte Marguerite" are "HIV Infections" (6 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Type 1 Diabetes" (3 trials), "Alzheimer's Disease" (2 trials) and "HIV-1 Infection" (2 trials). Many other conditions were trialed in "Hôpital Sainte Marguerite" in a lesser frequency.

Most popular intervention types in "Hôpital Sainte Marguerite" are "Drug" (22 trials), "Device" (8 trials), "Other" (8 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "placebo" (3 trials), "Dacarbazine" (2 trials), "ABI-007" (1 trials) and "ATAZANAVIR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Sainte Marguerite" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Sainte Marguerite". 2 are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Hôpital Sainte Marguerite, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Sainte Marguerite, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 12 trials that are defined as “Not Applicable".